3.1. Both the Isoform-Specific Bivalent- and Pan-BET Inhibitor Affect Proliferation and Metabolic Activity at Low Dosage in DLBCL and BL Cell Lines. The gene discussed is DNER; the disease is diffuse large B-cell lymphoma.